Penault-Llorca F - Search Results

1

[Assessment of HER2 status in breast cancer].

Penault-Llorca F, Cayre A. Penault-Llorca F, et al. Bull Cancer. 2004 Dec 1;91 Suppl 4:S211-5. Bull Cancer. 2004. PMID: 15899610 Free article. Review. French.

2

[Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?].

Penault-Llorca F, Jacquemier J. Penault-Llorca F, et al. Ann Pathol. 1999 Apr;19(2):103-15. Ann Pathol. 1999. PMID: 10349474 Review. French. No abstract available.

3

[Monoclonal antibodies in oncology: applications in diagnosis, prognosis and prediction of response to therapy on tissue specimens].

Penault-Llorca FM, Balaton AJ. Penault-Llorca FM, et al. Bull Cancer. 2000 Nov;87(11):794-803. Bull Cancer. 2000. PMID: 11125288 Free article. Review. French.

4

Pgp immunochemistry: use with caution: correspondence re: C-H. Kao et al., P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res., 61: 1412-1414, 2001.

Cayre A, Maublant J, Penault-Llorca F. Cayre A, et al. Cancer Res. 2002 Jan 15;62(2):617. Cancer Res. 2002. PMID: 11809718 No abstract available.

5

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F. Chollet P, et al. Br J Cancer. 2002 Apr 8;86(7):1041-6. doi: 10.1038/sj.bjc.6600210. Br J Cancer. 2002. PMID: 11953845 Free PMC article.

6

Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.

Cayre A, Cachin F, Maublant J, Mestas D, Feillel V, Ferrière JP, Kwiaktowski F, Chevillard S, Finat-Duclos F, Verrelle P, Penault-Llorca F. Cayre A, et al. Int J Oncol. 2002 May;20(5):1049-55. Int J Oncol. 2002. PMID: 11956603

7

[Immunochemistry evaluation of HER2 status in infiltration breast cancer: technical protocol and interpretation guidelines].

Penault-Llorca F, Balaton A, Sabourin JC, Le Doussal V; Groupe d'évaluation des facteurs pronostiques par immunohistochimie dans les cancers du sein (GEFPICS). Penault-Llorca F, et al. Ann Pathol. 2002 Apr;22(2):150-7. Ann Pathol. 2002. PMID: 12124503 French.

8

O(6)-methylguanine-DNA methyl transferase gene expression and prognosis in breast carcinoma.

Cayre A, Penault-Llorca F, De Latour M, Rolhion C, Feillel V, Ferrière JP, Kwiatkowski F, Finat-Duclos F, Verrelle P. Cayre A, et al. Int J Oncol. 2002 Nov;21(5):1125-31. Int J Oncol. 2002. PMID: 12370764

9

Current status of HER2 testing.

Di Leo A, Dowsett M, Horten B, Penault-Llorca F. Di Leo A, et al. Oncology. 2002;63 Suppl 1:25-32. doi: 10.1159/000066204. Oncology. 2002. PMID: 12422052 Review.

10

[Principal therapeutic uses of monoclonal antibodies in oncology].

Penault-Llorca F, Etessami A, Bourhis J. Penault-Llorca F, et al. Cancer Radiother. 2002 Nov;6 Suppl 1:24s-28s. doi: 10.1016/s1278-3218(02)00218-4. Cancer Radiother. 2002. PMID: 12587379 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters